RoPlaVac Overview

  • Founded
  • 2010
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 2

RoPlaVac General Information


Developer of a vaccination against malaria. The company develops a vaccine against malaria that can simultaneously protect against the two major species of malaria-causing parasites.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Laboratory Services (Healthcare)
Primary Office
  • Lisbon
  • Portugal
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

RoPlaVac Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 24-Apr-2014 Completed Startup
1. Grant 01-Nov-2010 Completed Startup
To view RoPlaVac’s complete valuation and funding history, request access »

RoPlaVac Executive Team (2)

Name Title Board Seat Contact Info
Antonio M. Mendes Co-Founder
Miguel Prudencio Co-Founder
To view RoPlaVac’s complete executive team members history, request access »

RoPlaVac Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Building Global Innovators Accelerator/Incubator 000 0000 000000 0
Bill & Melinda Gates Foundation Not-For-Profit Venture Capital Minority 000 0000 000000 0
To view RoPlaVac’s complete investors history, request access »